LTRN – lantern pharma inc. (US:NASDAQ)
Stock Stats
News
Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies [Yahoo! Finance]
Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television [Yahoo! Finance]
Lantern Pharma (NASDAQ:LTRN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Lantern Pharma Inc. For: Jan 22
Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: KEYSER D JEFFREY
Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Chandru Vijay
Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Silberstein David S.
Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Schalop Lee Troy
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.